1000 resultados para Corporative university


Relevância:

20.00% 20.00%

Publicador:

Resumo:

Newsletter on the activities of the University of Iowa Graduate College.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Newsletter on the activities of the University of Iowa Graduate College.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Newsletter on the activities of the University of Iowa Graduate College.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Newsletter on the activities of the University of Iowa Graduate College.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Newsletter on the activities of the University of Iowa Graduate College.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Report on the State University of Iowa, Iowa City, Iowa for the year ended June 30, 2013

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Report on Iowa State University of Science and Technology, Ames, Iowa, for the year ended June 30, 2013

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Report on the University of Northern Iowa for the year ended June 30, 2013

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Report on a special investigation of the University of Iowa Athletic Ticket Office and the operations of the Hawkeye Express for the period September 1, 2005 through November 30, 2013

Relevância:

20.00% 20.00%

Publicador:

Resumo:

This guide is designed as a finding aid for researchers seeking materials on a particular topic and it indicates the nature and extent of resources for the study of United States history available at the Historical Society of Iowa, the Herbert Hoover Presidential Library and the Iowa University Libraries.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

BACKGROUND: Many medicines used in newborns, infants, children and adolescents are not licensed ("unlicensed") or are prescribed outside the terms of the marketing authorization ("off-label"). Several studies have shown that this is a common practice in various healthcare settings in the USA, Europe and Australia, but data are scarce in Switzerland. OBJECTIVES: The aim of our prospective study was to determine the proportion of unlicensed or off-label prescriptions in paediatric patients. METHODS: This pilot study was conducted prospectively over a six month period in the department of paediatrics of a university hospital. RESULTS: Sixty patients aged from three days to 14 years were included in the study. A total of 483 prescriptions were written for the patients. More than half of all prescriptions (247; 51%) followed the terms of the marketing authorization. 114 (24%) were unlicensed and 122 (25%) off-label. All patients received at least one unlicensed or offlabel medicine. CONCLUSION: The use of unlicensed or off-label medicines to treat children was found to be common. Co-operation between the pharmaceutical industry, national regulatory authorities, clinical researchers, healthcare professionals and parents is required in order to ensure that children do not remain "therapeutic orphans".